TRANSURETHRAL RESECTION OF NON-MUSCLE-INVASIVE BLADDER TRANSITIONAL CELL CANCERS WITH OR WITHOUT 5-ALA UNDER VISIBLE AND FLUORESCENT LIGHT - MULTICENTER PHASE III CLINICAL TRIAL

Multicenter Phase ◽

Muscle Invasive

1009 TRANSURETHRAL RESECTION OF NON-MUSCLE-INVASIVE BLADDER TRANSITIONAL CELL CANCERS WITH OR WITHOUT 5-ALA UNDER VISIBLE AND FLUORESCENT LIGHT – MULTICENTER PHASE III CLINICAL TRIAL

European Urology Supplements ◽

10.1016/s1569-9056(09)60994-5 ◽

2009 ◽

Vol 8 (4) ◽

pp. 373 ◽

Cited By ~ 3

Author(s):

M.C. Schumacher ◽

S. Holmäng ◽

T. Davidsson ◽

B. Friedrich ◽

J. Pedersen ◽

...

Keyword(s):

Clinical Trial ◽

Transurethral Resection ◽

Transitional Cell ◽

Phase Iii ◽

Fluorescent Light ◽

Multicenter Phase ◽

Muscle Invasive

Efficacy and Safety of 400 and 800 mg Etodolac vs. 1,000 mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial

Pain Practice ◽

10.1111/j.1533-2500.2012.00572.x ◽

2012 ◽

Vol 13 (3) ◽

pp. 191-197 ◽

Cited By ~ 5

Author(s):

Vesile Öztürk ◽

Mustafa Ertaş ◽

Betül Baykan ◽

Hadiye Şirin ◽

Aynur Özge ◽

...

Keyword(s):

Clinical Trial ◽

Acute Treatment ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

European Urology ◽

10.1016/j.eururo.2020.04.066 ◽

2020 ◽

Vol 78 (5) ◽

pp. 690-698 ◽

Cited By ~ 5

Author(s):

Marc-Oliver Grimm ◽

Antoine G. van der Heijden ◽

Marc Colombel ◽

Tim Muilwijk ◽

Luis Martínez-Piñeiro ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Carcinoma ◽

European Association ◽

Standard Dose ◽

Phase Iii ◽

High Grade ◽

Muscle Invasive ◽

European Association Of Urology

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Epilepsy & Behavior ◽

10.1016/j.yebeh.2020.106962 ◽

2020 ◽

Vol 105 ◽

pp. 106962 ◽

Cited By ~ 3

Author(s):

Fenella Kirkham ◽

Stéphane Auvin ◽

Joana Moreira ◽

Helena Gama ◽

Amílcar C. Falcão ◽

...

Keyword(s):

Clinical Trial ◽

Adjunctive Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Multicenter Phase ◽

Parallel Group

RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL TRANSPLANTATION1,2

Transplantation Journal ◽

10.1097/00007890-199807150-00005 ◽

1998 ◽

Vol 66 (1) ◽

pp. 29-37 ◽

Cited By ~ 217

Author(s):

A. Osama Gaber ◽

M. Roy First ◽

Raymond J. Tesi ◽

Robert S. Gaston ◽

Robert Mendez ◽

...

Keyword(s):

Clinical Trial ◽

Graft Rejection ◽

Phase Iii ◽

Double Blind ◽

Acute Graft Rejection ◽

Multicenter Phase ◽

Acute Graft

Comparative Evaluation the Efficacy of 2L Polyethylene Glycol with Ascorbic Acid (PEG-Asc) and Oral Sulfate Solution (OSS) in Split Method for Bowel Preparation: A Randomized Multicenter Phase III Clinical Trial

The American Journal of Gastroenterology ◽

10.14309/00000434-201610001-00396 ◽

2016 ◽

Vol 111 ◽

pp. S179

Author(s):

Seong Dae Lee ◽

Bun Kim ◽

Kyung Su Han ◽

Byung Chang Kim ◽

Eui-Gon Youk ◽

...

Keyword(s):

Clinical Trial ◽

Ascorbic Acid ◽

Polyethylene Glycol ◽

Bowel Preparation ◽

Comparative Evaluation ◽

Sulfate Solution ◽

Phase Iii ◽

Split Method ◽

Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy children (6 months to 17 years of age): a randomized, multicenter, phase III clinical trial

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2020.1794683 ◽

2020 ◽

pp. 1-9

Author(s):

Sumantra Sarkar ◽

Chandrakant Bokade ◽

Kapil Garg ◽

Ravi Kumar ◽

Jayesh Sanmukhani ◽

...

Keyword(s):

Clinical Trial ◽

Influenza Vaccine ◽

Phase Iii ◽

Healthy Children ◽

Re: Marc-Oliver Grimm, Antione G. van der Heijden, Marc Colombel, et al. Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.066

European Urology ◽

10.1016/j.eururo.2020.06.060 ◽

2020 ◽

Vol 78 (4) ◽

pp. e161-e162

Author(s):

Emre Karabay ◽

İlker Tınay

Keyword(s):

Clinical Trial ◽

Bladder Carcinoma ◽

European Association ◽

Standard Dose ◽

Phase Iii ◽

Muscle Invasive ◽

European Association Of Urology

Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial

Archives of Physical Medicine and Rehabilitation ◽

10.1016/j.apmr.2020.03.025 ◽

2020 ◽

Vol 101 (9) ◽

pp. 1485-1496

Author(s):

Junekyung Lee ◽

Min Ho Chun ◽

Young Jin Ko ◽

Shi-Uk Lee ◽

Deog Young Kim ◽

...

Keyword(s):

Clinical Trial ◽

Upper Limb ◽

Active Drug ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Multicenter Phase ◽

Limb Spasticity

1137 A prospective, randomized, multicenter, phase III clinical trial of the effect of different initial therapy regimes and maintenance prophylaxis in superficial bladder cancer using mitomycin C

European Journal of Cancer ◽

10.1016/0959-8049(95)96383-o ◽

1995 ◽

Vol 31 ◽

pp. S238

Author(s):

D.W.W. Newling ◽

D. Mulder

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Mitomycin C ◽

Superficial Bladder Cancer ◽

Initial Therapy ◽

Phase Iii ◽